Dutsch, A.; Uhlig, C.; Bock, M.; Graesser, C.; Schuchardt, S.; Uhlig, S.; Schunkert, H.; Joner, M.; Holdenrieder, S.; Lechner, K.
Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19. J. Clin. Med. 2023, 12, 6225.
https://doi.org/10.3390/jcm12196225
AMA Style
Dutsch A, Uhlig C, Bock M, Graesser C, Schuchardt S, Uhlig S, Schunkert H, Joner M, Holdenrieder S, Lechner K.
Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19. Journal of Clinical Medicine. 2023; 12(19):6225.
https://doi.org/10.3390/jcm12196225
Chicago/Turabian Style
Dutsch, Alexander, Carsten Uhlig, Matthias Bock, Christian Graesser, Sven Schuchardt, Steffen Uhlig, Heribert Schunkert, Michael Joner, Stefan Holdenrieder, and Katharina Lechner.
2023. "Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19" Journal of Clinical Medicine 12, no. 19: 6225.
https://doi.org/10.3390/jcm12196225
APA Style
Dutsch, A., Uhlig, C., Bock, M., Graesser, C., Schuchardt, S., Uhlig, S., Schunkert, H., Joner, M., Holdenrieder, S., & Lechner, K.
(2023). Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19. Journal of Clinical Medicine, 12(19), 6225.
https://doi.org/10.3390/jcm12196225